World Site
EN
Albania
EN
Algeria
EN
Algeria
AR
Algeria
FR
Argentina
ES
Armenia
EN
Australia
EN
Austria
DE
Bahrain
EN
Bangladesh
EN
Belgium
FR
Belgium
NL
Bolivia
ES
Bosnia and Herzegovina
EN
Brazil
BR
Bulgaria
EN
Bulgaria
BG
Cambodia
EN
Canada
EN
Chile
ES
China
EN
China
CN
Croatia
EN
Czech Republic
EN
Egypt
EN
Egypt
AR
France
FR
Germany
DE
Hungary
EN
Hungary
HU
India
EN
Indonesia
EN
Indonesia
ID
Iraq
EN
Iraq
AR
Italy
EN
Italy
IT
Japan
EN
Japan
JP
Jordan
EN
Kazakhstan
EN
Korea
KO
Kuwait
EN
Kuwait
AR
Latvia
EN
Lebanon
EN
Luxembourg
EN
Luxembourg
DE
Malaysia
EN
Mexico
ES
Morocco
EN
Morocco
AR
Morocco
FR
Myanmar
EN
Netherlands
EN
Netherlands
NL
North Macedonia
EN
Oman
EN
Oman
AR
Philippines
EN
Poland
PL
Portugal
EN
Portugal
PT
Qatar
EN
Qatar
AR
Romania
EN
Romania
RO
Saudi Arabia
EN
Saudi Arabia
AR
Serbia
EN
Singapore
EN
Slovakia
EN
South Africa
EN
Spain
CA
Spain
ES
Sweden
EN
Switzerland
DE
Taiwan
EN
Taiwan
TW
Thailand
EN
Tunisia
EN
Tunisia
AR
Tunisia
FR
Turkey
EN
Turkey
TR
Uganda
EN
United Arab Emirates
EN
United Arab Emirates
AR
United Kingdom
EN
USA
EN
Vietnam
EN
Vietnam
VI
Today, following a request from the European Commission, the Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) provided Guidelines on the benefit-risk assessment of the presence, in the medical devices specified in the mandate, of phthalates which have one or more of the following properties: carcinogenic, mutagenic, toxic to reproduction (CMR) or endocrine-disrupting (ED).
On their basis, the Commission is launching a public consultation where interested parties are invited to submit their comments on the scientific evidence online by 29 April 2019.
These Guidelines describe the methodology on how to perform a benefit-risk assessment (BRA) for the justification of the presence of CMR 1A or 1B and/or ED phthalates (CMR/ED phthalates) in medical devices and/or or parts or materials used therein at percentages above 0.1% by weight (w/w). They also consider the evaluation of possible alternatives for these phthalates used in medical devices. They are intended to be used by the relevant stakeholders e.g. manufacturers, notified bodies and regulatory bodies. The approach of these Guidelines may also be used for a BRA of other CMR/ED substances present in medical devices.
Source Link: Click here
On February 2019, four Decisions are enacted and announced by Egyptian Ministry of Trade and Industry . Manufacturers and importers of certain products are granted a transitional period of 6 months or more to comply with approved mandatory standards on safety, energy efficiency etc.
Concerned products include:
The four decisions will be published by the Ministry in near future.
Source Link: Click here
On February, France published a list of safety standards for Bicycles and Electric-assisted Bicycles.
And a transitional period is provided:
"Products conforming to standards whose references have been published in the Official Journal of the French Republic by the notice of 11 July 2015 may be placed on the market until 13 April 2019 and marketed while supplies last. However, electric-assisted cycles in accordance with NF EN 15194 + A1 (January 2012) can be marketed until April 13, 2020 and marketed while supplies last. "
Source Link: Click here
Draft amendment to the Transport Regulations published by Israel Ministry of Transport and Road Safety. This draft amendment lowers trade barriers and includes the following major changes:
Source Link: Click here
New Zealand Ministry of Transport is revising the 2002 Land Transport Rule: Light-vehicle Brakes. There is a compelling case for mandating Advanced Braking Systems (ABS) as soon as possible because of the safety benefit it brings to motorcyclists. This amendment will incorporate updated minimum standards for new motorcycles, and in particular will introduce a requirement for advanced brake systems for motorcycles meeting internationally recognised standards from Australia, Europe, Japan and the United States entering the fleet. New model new motorcycles will need to comply with one of the four international standards from November 2019. Existing and used motorcycles will need to comply with these standards from November 2021. The reason the rule is proposed to be implemented on these dates is to reduce the risk of New Zealand receiving less safe motorbikes, with Australia bringing in these requirements on the same dates. The revised Rule will require advanced braking systems (anti-lock brakes or a combined braking system) for motorcycles, depending on the powerband. It will continue existing minimum standards for existing models and used vehicles, until 1 November 2021.
The proposed new braking standards are applicable in Europe, the United States, Japan and Australia, are internationally recognised and accepted in the international motor manufacturing industry. We do not anticipate that this rule change will produce a significant barrier to trade. The proposed restrictions relate only to registrations of motorcycles for the use of public roads.
Non-compliant motorcycles will still be able to be used off-road. The approved vehicle standards for brakes are:
Source Link: Click here